The Drug Eluting Stents Center

Filter Your Results




DISAPEAR Registry Evaluates Abbott’s Absorb BVS in Asian Cohort With CLTI

November 6, 2019 -- One-year results from the DISAPEAR registry evaluating the Absorb bioresorbable vascular scaffold (BVS; Abbott) were presented by Steven Kum, MD, in a late…

Five-Year Results From ABSORB BTK Trial Presented

November 6, 2019 -- The 5-year results of the ABSORB BTK trial -- a prospective, nonrandomized, single-center study evaluating a novel bioresorbable, drug-eluting scaffold for…

Trial Data Presented for Boston Scientific's Ranger DCB and Eluvia DES

November 5, 2019 -- Boston Scientific Corporation announced positive data for two devices within its peripheral drug-eluting product portfolio during separate late-breaking cl…

Five-Year Data Analysis Shows Benefit, No Increased Mortality With Cook Medical’s Zilver PTX Across Different Patient Groups

November 5, 2019 -- Cook Medical announced that data supporting the benefits of the company’s Zilver PTX paclitaxel-coated stent to treat peripheral artery disease (PAD)…

Surmodics’ Sundance SCB Catheter Earns FDA Breakthrough Device Designation

October 29, 2019 -- Surmodics, Inc. announced that the company’s Sundance sirolimus-coated balloon (SCB) catheter has been granted Breakthrough Device designation from t…

Meta-Analysis Shows Heterogeneity in Benefits and Risks With Paclitaxel-Coated Balloons

October 21, 2019 -- Jena University Hospital in Jena, Germany, announced the publication of findings from a meta-analysis conducted by the institution that sought to evaluate …

Concept Medical’s MagicTouch Sirolimus-Coated Devices Gain CE Mark Approval

October 18, 2019 -- Concept Medical has announced European CE Mark approval for its MagicTouch line of sirolimus-coated devices. These include the MagicTouch PTA, a sirolimus-…

Philips Introduces 200-mm and 150-mm Stellarex 0.035-Inch Low-Dose DCBs

October 15, 2019 -- Royal Philips announced the United States introduction of two new balloons to its Stellarex 0.035-inch low-dose drug-coated balloon (DCB) portfolio. The ne…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.